ACP

Acuta Capital Partners Portfolio holdings

AUM $71.6M
1-Year Return 169.78%
This Quarter Return
+21.43%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$277M
AUM Growth
-$85.9M
Cap. Flow
-$56.8M
Cap. Flow %
-20.47%
Top 10 Hldgs %
45.56%
Holding
64
New
13
Increased
10
Reduced
20
Closed
17

Top Buys

1
VTGN icon
VistaGen Therapeutics
VTGN
$10.2M
2
SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
$8.58M
3
EPIX icon
ESSA Pharma
EPIX
$8.34M
4
ACRS icon
Aclaris Therapeutics
ACRS
$8.01M
5
VINC
Vincerx Pharma, Inc. Common Stock
VINC
$7.6M

Top Sells

1
LRMR icon
Larimar Therapeutics
LRMR
$18.5M
2
IMVT icon
Immunovant
IMVT
$13.1M
3
CLDX icon
Celldex Therapeutics
CLDX
$12.6M
4
SAGE
Sage Therapeutics
SAGE
$10.3M
5
SURF
Surface Oncology, Inc. Common Stock
SURF
$9.24M

Sector Composition

1 Healthcare 91.38%
2 Financials 5.21%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
APLS icon
26
Apellis Pharmaceuticals
APLS
$3.55B
$4.86M 1.75%
113,161
-53,893
-32% -$2.31M
GYRE icon
27
Gyre Therapeutics
GYRE
$698M
$4.74M 1.71%
125,267
-55,733
-31% -$2.11M
RAPT icon
28
RAPT Therapeutics
RAPT
$214M
$4.45M 1.6%
25,036
-1,164
-4% -$207K
OBIO icon
29
Orchestra BioMed
OBIO
$148M
$4.39M 1.58%
392,500
– –
CLSD icon
30
Clearside Biomedical
CLSD
$27.2M
$3.99M 1.44%
1,614,000
+364,000
+29% +$899K
EYPT icon
31
EyePoint Pharmaceuticals
EYPT
$966M
$3.87M 1.4%
+381,145
New +$3.87M
RNAC icon
32
Cartesian Therapeutics
RNAC
$277M
$3.72M 1.34%
+27,433
New +$3.72M
CMPS
33
Compass Pathways
CMPS
$493M
$3.31M 1.19%
90,000
-229,000
-72% -$8.43M
IOVA icon
34
Iovance Biotherapeutics
IOVA
$901M
$3.09M 1.11%
97,574
-67,226
-41% -$2.13M
VINCW
35
DELISTED
Vincerx Pharma, Inc. Warrant
VINCW
$2.1M 0.76%
+520,000
New +$2.1M
RNA icon
36
Avidity Biosciences
RNA
$6.48B
$1.79M 0.64%
82,000
-164,200
-67% -$3.58M
STOK icon
37
Stoke Therapeutics
STOK
$1.13B
$1.75M 0.63%
45,000
-47,500
-51% -$1.85M
MRTX
38
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.54M 0.56%
+9,000
New +$1.54M
INSM icon
39
Insmed
INSM
$30.7B
$1.45M 0.52%
+42,500
New +$1.45M
CBAY
40
DELISTED
Cymabay Therapeutics
CBAY
$1.43M 0.52%
315,341
-14,659
-4% -$66.6K
RETA
41
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$1.4M 0.5%
+14,000
New +$1.4M
FDMT icon
42
4D Molecular Therapeutics
FDMT
$340M
$868K 0.31%
20,000
– –
NVAX icon
43
Novavax
NVAX
$1.28B
$569K 0.21%
3,136
+636
+25% +$115K
PMVP icon
44
PMV Pharmaceuticals
PMVP
$77.4M
$456K 0.16%
13,856
-1,144
-8% -$37.6K
CPRX icon
45
Catalyst Pharmaceutical
CPRX
$2.48B
$360K 0.13%
+78,000
New +$360K
NUVB.WS icon
46
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$64.6M
$249K 0.09%
+93,332
New +$249K
ALDX icon
47
Aldeyra Therapeutics
ALDX
$334M
– –
-192,500
Closed -$1.32M
ANNX icon
48
Annexon
ANNX
$238M
– –
-25,000
Closed -$626K
AXSM icon
49
Axsome Therapeutics
AXSM
$6.25B
– –
-6,000
Closed -$489K
CCCC icon
50
C4 Therapeutics
CCCC
$194M
– –
-110,000
Closed -$3.64M
1
2
3